New York, NY — March, 10 2026
Biolux Technology will introduce OrthoPulse® Lite, the next generation of near-infrared photobiomodulation technology designed to support faster, more predictable orthodontic treatment. The system will be showcased at the 2026 American Association of Orthodontists (AAO) Annual Session, May 1–3 in Orlando.
OrthoPulse lite was designed to expand access to photobiomodulation therapy across a broader range of orthodontic practices, with seamless integration across every orthodontic case, including aligners, fixed appliances, hybrid protocols, and comprehen-sive cases.
Built on the proven science behind OrthoPulse, the lite platform delivers advanced near-infrared light therapy through simplified clinical protocols that support biological response during tooth movement while enhancing comfort and patient engagement.
All current and future shipments incorporate the latest software enhancements, reflecting Biolux’s continued commitment to product performance and clinical reliability.
Orthodontics continues to move toward more efficient, technology-enabled care,” said Chuck Abraham, CEO of Biolux Technology. “OrthoPulse lite provides a practical, scalable solution that supports predictable treatment while improving the overall patient experience.
Clinical evidence has demonstrated improved treatment efficiency and reduced finishing refinements when OrthoPulse is used as an adjunct to orthodontic treatment, reinforcing its value for practices focused on performance, predictability, and patient satisfaction.
At AAO 2026, attendees will learn how OrthoPulse lite integrates directly into modern digital workflows, including:
• Near-infrared therapy supporting biologic tooth movement
• Simple integration into existing orthodontic workflows
• Improved patient comfort and compliance
• Compatible with aligners, braces, and hybrid treatment protocols
The AAO Annual Session brings together thousands of orthodontic professionals to explore emerging technologies and clinical advancements, providing the ideal setting to introduce this next-generation platform.
Visit Booth #1268 for live demonstrations, clinical discussion, and implementation guidance on how OrthoPulse lite can be deployed immediately across your entire patient base.
About OrthoPulse
OrthoPulse is the pioneer in near-infrared photobiomodulation therapy for orthodontics and the only FDA-cleared device indicated as an adjunct to orthodontic treatment. With a growing global presence and regulatory approvals across major international markets, OrthoPulse supports improved efficiency, enhanced comfort, and predictable outcomes for both aligner and fixed appliance workflows.
Learn more at: www.orthopulse.com
Media Contact:
Michael Hendricks
Chief Revenue Officer, Biolux Technology USA LLC